
The development of new drug therapies has historically been a slow and expensive journey, often taking decades and billions of dollars before reaching patients. Today, artificial intelligence is changing that…

The development of new drug therapies has historically been a slow and expensive journey, often taking decades and billions of dollars before reaching patients. Today, artificial intelligence is changing that…

Massachusetts has led the biotech revolution, but in today’s race for talent, we risk falling behind — held back not by science, but by credentialing systems. We’re watching from an…